相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis
Jianfeng Wang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Statin use and risk of liver cancer: Evidence from two population-based studies
Kim Tu Tran et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Epidemiological and etiological variations in hepatocellular carcinoma
Evangelista Sagnelli et al.
INFECTION (2020)
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh et al.
HEPATOLOGY (2020)
Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
Sang-Wook Yi et al.
BRITISH JOURNAL OF CANCER (2020)
Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
Xiaofei Li et al.
BMC GASTROENTEROLOGY (2020)
Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis
Yue Chang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Karl Bjorkstrom et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis
David E. Kaplan et al.
GASTROENTEROLOGY (2019)
Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B
Gi-Ae Kim et al.
YONSEI MEDICAL JOURNAL (2019)
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
An Tang et al.
ABDOMINAL RADIOLOGY (2018)
The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study
David E. Dawe et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
Gyuri Kim et al.
JOURNAL OF HEPATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
Gyuri Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation
Latifa Bakiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink
Katherine A. McGlynn et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
Ashwin N. Ananthakrishnan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis
Arpan Mohanty et al.
GASTROENTEROLOGY (2016)
Atorvastatin and Fluvastatin Are Associated With Dose-Dependent Reductions in Cirrhosis and Hepatocellular Carcinoma, Among Patients With Hepatitis C Virus: Results From ERCHIVES
Tracey G. Simon et al.
HEPATOLOGY (2016)
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2016)
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding
Gary D. Friedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
Yao-Yao Zhou et al.
ONCOTARGET (2016)
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding
Gary D. Friedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
Lee-Won Chong et al.
BMC GASTROENTEROLOGY (2015)
Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
Adeel A. Butt et al.
HEPATOLOGY (2015)
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
John Chen Hsiang et al.
JOURNAL OF HEPATOLOGY (2015)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
Laura Galli et al.
AIDS (2014)
Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies
Yanqiong Liu et al.
CANCER CAUSES & CONTROL (2014)
Statin use and risk of hepatocellular carcinoma in a US population
Katherine A. McGlynn et al.
CANCER EPIDEMIOLOGY (2014)
Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
Sonal Kumar et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
LIVER CANCER IN 2013 Mutational landscape of HCC-the end of the beginning
Augusto Villanueva et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden
Linda Bjorkhem-Bergman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Novel prospects of statins as therapeutic agents in cancer
Simona Pisanti et al.
PHARMACOLOGICAL RESEARCH (2014)
Statin use and risk of liver cancer: an update meta-analysis
Meng Shi et al.
BMJ OPEN (2014)
Statins and primary liver cancer: a meta-analysis of observational studies
Danitza Pradelli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: A comprehensive review
Simon Zeichner et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2012)
Potential for statins in the chemoprevention and management of hepatocellular carcinoma
Amedeo Lonardo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Jonathan R. Emberson et al.
PLOS ONE (2012)
Statin Use and the Risk of Liver Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Hepatitis C virus: How genetic variability affects pathobiology of disease
Kazuaki Chayama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Statins and Risk of Cancer A Retrospective Cohort Analysis of 45,857 Matched Pairs From an Electronic Medical Records Database of 11 Million Adult Americans
Claudio Marelli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy
Stephen A. Harrison et al.
HEPATOLOGY (2010)
Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells
Borna Relja et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Yasuyuki Matsushita et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
835 Insulin Treatment and the Risk of Hepatocellular Carcinoma in Patients with Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
Leen Delang et al.
HEPATOLOGY (2009)
Up-Regulated MicroRNA-143 Transcribed by Nuclear Factor kappa B Enhances Hepatocarcinoma Metastasis by Repressing Fibronectin Expression
Xiaoying Zhang et al.
HEPATOLOGY (2009)
Nonstructural 5A protein activates β-catenin signaling cascades: Implication of hepatitis C virus-induced liver pathogenesis
Chul-Yong Park et al.
JOURNAL OF HEPATOLOGY (2009)
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients
Gary D. Friedman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2007)
Pravastatin use and the five-year incidence of cancer in coronary heart disease patients: from the prevention of coronary sclerosis study
Shinichi Sato et al.
JOURNAL OF EPIDEMIOLOGY (2006)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors.: Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor
AP Sutter et al.
JOURNAL OF HEPATOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Cancer risk among statin users: A population-based cohort study
S Friis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
CM Shachaf et al.
NATURE (2004)
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation
J Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Statins as a newly recognized type of immunomodulator
B Kwak et al.
NATURE MEDICINE (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
